SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-24-083533
Filing Date
2024-04-01
Accepted
2024-04-01 16:48:57
Documents
1
Effectiveness Date
2024-04-01

Document Format Files

Seq Description Document Type Size
1 S-8 POS d759208ds8pos.htm S-8 POS 32575
  Complete submission text file 0001193125-24-083533.txt   33683
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-254039 | Film No.: 24810314
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)